These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 12792800)

  • 1. Prophylactic, therapeutic and anti-metastatic effects of BMDC and DC lines in mice carrying HPV 16-associated tumours.
    Mendoza L; Bubeník J; Símová J; Jandlová T; Vonka V; Mikysková R
    Int J Oncol; 2003 Jul; 23(1):243-7. PubMed ID: 12792800
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of minimal residual disease after surgery or chemotherapy in mice carrying HPV16-associated tumours: Cytokine and gene therapy with IL-2 and GM-CSF.
    Mikysková R; Indrová M; Símová J; Jandlová T; Bieblová J; Jinoch P; Bubeník J; Vonka V
    Int J Oncol; 2004 Jan; 24(1):161-7. PubMed ID: 14654953
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumour-inhibitory and antimetastatic effects of IL-2 in mice carrying MHC class I- tumours of HPV16 origin.
    Indrová M; Bubeník J; Mikysková R; Vonka V; Smahel M; Zák R; Símová J; Bieblová J; Mendoza L; Jandlová T
    Int J Oncol; 2002 Mar; 20(3):643-6. PubMed ID: 11836582
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Local cytokine treatment of HPV16-associated tumours results in inhibition of their lung metastases.
    Mikysková R; Bubenik J; Mendoza L; Vonka V; Smahel M; Símová J; Jandlová T
    Clin Exp Metastasis; 2000; 18(7):581-7. PubMed ID: 11688963
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumour-inhibitory effects of dendritic cells administered at the site of HPV 16-induced neoplasms.
    Mendoza L; Bubeník J; Símová J; Korb J; Bieblová J; Vonka V; Indrová M; Mikysková R; Jandlová T
    Folia Biol (Praha); 2002; 48(3):114-9. PubMed ID: 12118725
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metastatic MHC class I-negative mouse cells derived by transformation with human papillomavirus type 16.
    Smahel M; Sobotková E; Bubeník J; Símová J; Zák R; Ludviková V; Hájková R; Kovarík J; Jelínek F; Povýsil C; Marinov J; Vonka V
    Br J Cancer; 2001 Feb; 84(3):374-80. PubMed ID: 11225590
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin 2 gene therapy of residual disease in mice carrying tumours induced by HPV 16.
    Bubeník J; Símová J; Hájková R; Sobota V; Jandlová T; Smahel M; Sobotková E; Vonka V
    Int J Oncol; 1999 Mar; 14(3):593-7. PubMed ID: 10024696
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune escape phenotype of HPV16-associated tumours: MHC class I expression changes during progression and therapy.
    Mikysková R; Bubeník J; Vonka V; Smahel M; Indrova M; Bieblová J; Símová J; Jandlová T
    Int J Oncol; 2005 Feb; 26(2):521-7. PubMed ID: 15645139
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peritumoral administration of antigen-unstimulated bone marrow-derived dendritic cells inhibits tumour growth.
    Mendoza L; Indrová M; Hájková R; Reinis M; Smahel M; Vonka V; Bubeník J; Jandlová T
    Folia Biol (Praha); 2000; 46(3):91-7. PubMed ID: 10925779
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Local IFN-gamma therapy of HPV16-associated tumours.
    Mikysková R; Bieblová J; Símová J; Indrová M; Jandlová T; Vonka V; Smahel M; Bubeník J; Mendoza L
    Folia Biol (Praha); 2003; 49(1):26-32. PubMed ID: 12630665
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin-2 and dendritic cells as adjuvants for surgical therapy of tumours associated with human papillomavirus type 16.
    Bubeník J; Mikysková R; Vonka V; Mendoza L; Símová J; Smahel M; Indrová M
    Vaccine; 2003 Feb; 21(9-10):891-6. PubMed ID: 12547599
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemoimmunotherapy in mice carrying HPV16-associated, MHC class I+ and class I- tumours: Effects of CBM-4A potentiated with IL-2, IL-12, GM-CSF and genetically modified tumour vaccines.
    Indrová M; Bubeník J; Mikysková R; Mendoza L; Símová J; Bieblová J; Jandlová T; Jinoch P; Smahel M; Vonka V; Pajtasz-Piasecka E
    Int J Oncol; 2003 Mar; 22(3):691-5. PubMed ID: 12579325
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapy of HPV 16-associated carcinoma with dendritic cell-based vaccines: in vitro priming of the effector cell responses by DC pulsed with tumour lysates and synthetic RAHYNIVTF peptide.
    Indrová M; Bubeník J; Símová J; Vonka V; Nemecková S; Mendoza L; Reinis M
    Int J Mol Med; 2001 Jan; 7(1):97-100. PubMed ID: 11115616
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HPV16-associated tumours: therapy of surgical minimal residual disease with dendritic cell-based vaccines.
    Reinis M; Indrová M; Mendoza L; Mikysková R; Bieblová J; Bubeník J; Símová J
    Int J Oncol; 2004 Oct; 25(4):1165-70. PubMed ID: 15375569
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of tumor progression by transcriptional profiling of mouse MK16 cell lines transformed with human papillomavirus type 16 E6 and E7 oncogenes and activated H-ras.
    Smahel M; Smahelová J; Tejklová P; Tachezy R; Jelínek F
    Oncol Rep; 2005 Dec; 14(6):1665-74. PubMed ID: 16273273
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemotherapy, IL-12 gene therapy and combined adjuvant therapy of HPV 16-associated MHC class I-proficient and -deficient tumours.
    Indrová M; Bieblová J; Jandlová T; Vonka V; Pajtasz-Piasecka E; Reinis M
    Int J Oncol; 2006 Jan; 28(1):253-9. PubMed ID: 16328003
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunotherapy of HPV 16-associated tumours with tumour cell line/dendritic cell line (TC-1/DC2.4) hybrid vaccines.
    Símová J; Bieblová J; Jandlová T; Bubeník J
    Folia Biol (Praha); 2003; 49(5):203-6. PubMed ID: 14680295
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MHC class I+ and class I- HPV16-associated tumours expressing the E7 oncoprotein do not cross-react in immunization/challenge experiments.
    Símová J; Mikysková R; Vonka V; Bieblová J; Bubeník J; Jandlová T
    Folia Biol (Praha); 2003; 49(6):230-4. PubMed ID: 14748438
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Freezing and thawing of murine bone marrow-derived dendritic cells does not alter their immunophenotype and antigen presentation characteristics.
    Mendoza L; Bubeník J; Indrová M; Bieblová J; Vonka V; Símová J
    Folia Biol (Praha); 2002; 48(6):242-5. PubMed ID: 12512800
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adjuvant cytokine treatment of minimal residual disease after surgical therapy in mice carrying HPV16-associated tumours: cytolytic activity of spleen cells from tumour regressors.
    Indrová M; Mikysková R; Jandlová T; Vonka V; Bubeník J; Bieblová J
    Folia Biol (Praha); 2003; 49(6):217-22. PubMed ID: 14748435
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.